Michigan Business & Entrepreneurial Law Review
Menu
  • Home
  • About MBELR
    • Current Editorial Board
    • Past Boards
      • Volume 11
      • Volume 10
      • Volume 9
      • Volume 8
      • Volume 7
      • Volume 6
      • Volume 5
      • Volume 4
      • Volume 3
      • Volume 2
      • Volume 1
    • Subscribe
    • Submit Work
  • Print
    • Current Issue
    • Archive
  • MBELR Blog
    • Blog Posts
      • Vol. 14 Blog Posts
      • Vol. 13 Blog Posts
      • Vol. 12 Blog Posts
Menu

Tag: Pfizer

Lawsuits Against Pfizer Dismissed

Posted on March 19, 2018 by Blake Purdy

  Pfizer Inc. is one of the world’s largest pharmaceutical companies and is one of the thirty companies used to calculate the Dow Jones Industrial Average. In a class action, over one thousand lawsuits have been filed against Pfizer, claiming that certain testosterone replacement drugs increase the risk of heart attacks and strokes.1 Testosterone replacement…

The Modern Merger

Posted on February 22, 2016 by Jesse Taylor

The business world welcomed news of Pfizer’s plans to acquire Allergen in a $160 billion deal.1. The merger not only represents the biggest pharmaceutical merger of all time, but is also viewed as an indication that the business world is back on its feet as deal activity is surpassing all pre-recession metrics.2. While many positives…

© 2025 Michigan Business & Entrepreneurial Law Review | Powered by Minimalist Blog WordPress Theme